您的当前位置:首页 > Exploration > 【dog-friendly weekend getaways near new york ny】When Can We Expect A Profit From Oasmia Pharmaceutical AB (publ) (STO:OASM)? 正文
时间:2024-09-29 12:23:36 来源:网络整理 编辑:Exploration
Want to help shape the future of investing tools? Participate in ashort research studyand receive a dog-friendly weekend getaways near new york ny
Want to help shape the future of investing tools?dog-friendly weekend getaways near new york ny Participate in a
short research study
and receive a 6-month subscription to the award winning Simply Wall St research tool (valued at $60)!
Oasmia Pharmaceutical AB (publ)’s (
STO:OASM
)
: Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. The company’s loss has recently broadened since it announced a -kr118.0m loss in the full financial year, compared to the latest trailing-twelve-month loss of -kr153.3m, moving it further away from breakeven. As path to profitability is the topic on OASM’s investors mind, I’ve decided to gauge market sentiment. Below I will provide a high-level summary of the industry analysts’ expectations for OASM.
Check out our latest analysis for Oasmia Pharmaceutical
According to the industry analysts covering OASM, breakeven is near. They expect the company to post a final loss in 2019, before turning a profit of kr87m in 2020. So, OASM is predicted to breakeven approximately a few months from now. What rate will OASM have to grow year-on-year in order to breakeven on this date? Using a line of best fit, I calculated an average annual growth rate of 116%, which is extremely buoyant. If this rate turns out to be too aggressive, OASM may become profitable much later than analysts predict.
OM:OASM Past Future Earnings February 1st 19
I’m not going to go through company-specific developments for OASM given that this is a high-level summary, though, bear in mind that generally biotechs, depending on the stage of product development, have irregular periods of cash flow. This means that a high growth rate is not unusual, especially if the company is currently in an investment period.
One thing I’d like to point out is that OASM has managed its capital prudently, with debt making up 31% of equity. This means that OASM has predominantly funded its operations from equity capital,and its low debt obligation reduces the risk around investing in the loss-making company.
Next Steps:
There are key fundamentals of OASM which are not covered in this article, but I must stress again that this is merely a basic overview. For a more comprehensive look at OASM, take a look at
OASM’s company page on Simply Wall St
. I’ve also compiled a list of relevant aspects you should further research:
Valuation
: What is OASM worth today? Has the future growth potential already been factored into the price? The
intrinsic value infographic in our free research report
helps visualize whether OASM is currently mispriced by the market.
Management Team
: An experienced management team on the helm increases our confidence in the business – take a look at
who sits on Oasmia Pharmaceutical’s board and the CEO’s back ground
.
Other High-Performing Stocks
: Are there other stocks that provide better prospects with proven track records? Explore our
free list of these great stocks here
.
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at
.
View comments
REFILE-Taiwan scrambles diplomats to keep flights going amid China virus inclusion2024-09-29 12:11
Do Its Financials Have Any Role To Play In Driving Tracsis plc's (LON:TRCS) Stock Up Recently?2024-09-29 12:01
Click here to download this week's issue2024-09-29 11:46
Microsoft (MSFT) Debuts Surface Go in India via Flipkart2024-09-29 11:26
Arch Coal (ARCH) Down 22.8% Since Last Earnings Report: Can It Rebound?2024-09-29 11:24
How Much Are Bar Harbor Bankshares (NYSEMKT:BHB) Insiders Spending On Buying Shares?2024-09-29 11:04
Biocartis Group NV: Disclosure of a transparency notification2024-09-29 10:48
Addiction Treatment Specialist Discusses Overcoming Obstacles in Addiction Recovery2024-09-29 10:48
The Returns At Treatt (LON:TET) Provide Us With Signs Of What's To Come2024-09-29 10:42
Shiba Inu and 9 More of the Biggest Hits in Crypto for 20212024-09-29 09:48
Meritor to Cut Global Salaried Workers on Coronavirus Scare2024-09-29 12:22
HIGHLIGHTS-India unveils budget aimed at tackling rural distress2024-09-29 12:19
Verizon, Hearst Television reach deal to avoid blackout in some U.S. markets2024-09-29 12:12
BRIEF-Eurocrane China's Shareholder To Unload Up To 5 Pct Stake Between March 4 And Aug 12024-09-29 12:03
Unusual Options Activity Insight: Plug Power2024-09-29 11:47
Does Vectrus, Inc. (NYSE:VEC) Have A High Beta?2024-09-29 11:36
Bitcoin – Holds on to $4,000 Levels as the Bears Make a Move2024-09-29 11:29
How Many Insiders Sold Churchill Downs Incorporated (NASDAQ:CHDN) Shares?2024-09-29 10:23
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Groupon, Inc. (GRPN)2024-09-29 10:17
How Many Insiders Sold Churchill Downs Incorporated (NASDAQ:CHDN) Shares?2024-09-29 09:47